References
- O’Brien PJ, Klip A, Britt BA, Kalow BI. Malignant hyperthermia susceptibility: Biochemical basis for patho-genesis and diagnosis. Can J Vet Res. 1990; 54: 83-92.
- Pessah NI, Allen DP. Malignant hyperthermia. Best Pract Res Clin Anaesth. 2001; 15(2): 277-228.
- Ali ZS, Taguchi A, Rosenberg H. Malignant hyperthermia. Clin Anaesth. 2003; 17(3): 519-533.
- Robinson R, Hopkins P, Carsana A, Gilly H, Halsall J, Heytens L, et al. Several interacting genes influence the malignant hyperthermia phenotype. Hum Genet. 2003; 112(2): 217-218.
- Robinson R, Carpenter D, Shaw MA, Halsall J, Hopkins P. Mutations in RYR1 in malignant hyperthermia and central core disease. Hum Mutat. 2006; 27(10): 977-989.
- Quane KA, Ording H, Keating KE, Manning BM, Heine R, Bendixen D, et al. Detection of a novel mutation at amino acid position 614 in the ryanodine receptor in malignant hyperthermia. Br J Anaesth. 1997; 79(3): 332-337.
- Wu S, Ibarra MC, Malicdan MC, Murayama K, Ichihara Y, et al. Central core disease is due to RYR1 mutations in more than 90% of patients. Brain. 2006; 129(Pt 6): 1470-1480.
- Rosenborg H, Davis M, James D, Pollock D, Stowel K. Malignant hyperthermia. Orphanet J Rare Dis. 2007; 2: 21. doi: 10.1186/1750-1172-2-21.
- Bannister RA, Estève E, Eltit JM, Pessah IN, Allen PD, López JR, et al. A malignant hyperthermia-inducing mutation in RYR1 (R163C): Consequent alterations in the functional properties of DHPR channels. J Gen Physiol. 2010; 135(6): 629-640.
- Feng W, Barrientos G, Cherednichenko G, Yang T, Padilla T, Truong K, et al. Functional and biochemical properties of ryanodine receptor type 1 channels from heterozygous R163C malignant hyperthermia-susceptible mice. Mol Pharmacol. 2011; 79(3): 420-431.
- Eltit JM, Yang T, Li H, Molinski TF, Pessah IN, Allen PD, et al. RyR1-mediated Ca2+ leak and Ca2+ entry determine resting intracellular Ca2+ in skeletal myotubes. J Biol Chem. 2010; 285(18): 13781-13787.
- Schmidt GR, Kastenschmidt LL, Cassens RG, Briskey EJ. Serum enzyme and electrolyte levels of stress resistant Chester White pigs and stress susceptible Poland China pigs. J Anim Sci. 1970; 31(6): 1168-1171.
- Heffron J. Malignant hyperthermia: Biochemical aspects of the acute episode. Br J Anaesth. 1988; 60: 274-278.
- Darrah PS, DiMaeco NM, Beitz DC, Topel DG. Conversion of alanine, aspartate and lactate to glucose and CO2 in liver from stress-susceptible and stress-resistant pigs. J Nutr. 1979; 109(8): 1464-1468.
- McLaughlin JV, Mothermill C. Halothane-induced rigidity and associated glycolytic and energy phosphate changes in red and white fibres of skeletal muscle of pig. J Comp Pathol. 1976; 86(3): 465-476.
- Kruff B, Frahm K. Use of the creatine kinase test in piglet. Pig News and Information. 1985; 6(2): 1-5.
- Stalder KJ. Effects of porcine stress syndrome genotype on maternal traits in swine. 1995. Ph.D. Thesis. Iowa State University, Ames, IA, USA.
- Fujii J, Otsu K, Zorzato F, de Leon S, Khanna VK, Weiler JE. Identification of a mutation in porcine ryanodine receptor associated with malignant hyperthermia. Science. 1991; 253(5018): 448-451
- Nelson TE, Jones EW, Henrickson RL, Falk SN, Kerr DD.: Porcine malignant hyperthermia. Observation on the occurrence of pale, soft and excudative musculature among susceptable pigs. J Vet Res. 1974; 35(3): 347-350.
- Schaefer AL, Doornenbal H, Sather AP, Tong AKW, Jones SDM, Murray AC. The use of blood serum components in the identification of stress-susceptible and carrier pigs. Can J Anim Sci. 1990; 70: 845-855.
- Ellis FR, Heffron JJA. Clinical and biochemical aspects of malignant hyperpyrexia. In: Atkinson RS, Adams AP, Eds. Recent Advances in Anesthesia and Analgesia. Edinburgh, UK: Churchill-Livingstone. 1985: 173-207.
- Mabry JW, Christian LL, Kuhlers DL, Rasmusen BA. Prediction of susceptibility to the porcine stress syndrome. J Hered. 1983; 74(1): 23-26.